Search Within

Hira Abbas Rizvi

Formats
  1. Journal Article (65)
  2. Meeting Abstract (58)
Groups
  1. Department of Medicine (123)
  2. Solid Tumor Oncology Division (123)
  3. Thoracic Oncology (121)
  4. Hematology-Oncology Fellows (81)
  5. GSK Faculty (67)
  6. Weinberg Fellows (67)

More Groups

People
  1. Matthew Hellmann (97)
  2. Gregory Riely (42)
  3. Andrew Plodkowski (41)
  4. Charles Rudin (37)
  5. Mark Kris (34)
  6. Kathryn Arbour (32)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (8)
  4. 2022 (17)
  5. 2021 (23)
  6. 2020 (25)

More Years

Publications
  1. Journal of Clinical Oncology (35)
  2. Journal of Thoracic Oncology (16)
  3. Annals of Oncology (12)
  4. Clinical Cancer Research (12)
  5. Cancer Research (10)
  6. Cancer Cell (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (37)
  2. American Association for Cancer Research (28)
  3. Elsevier Inc. (20)
  4. Oxford University Press (13)
  5. Cell Press (7)
  6. American Medical Association (4)

More Publishers

Results (123)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Defining real-world recurrence in the AACR Project GENIE Biopharma Collaborative Data
    Meeting Abstract

    Lavery, J. A.; Brown, S.; Lepisto, E.; Lenoue-Newton, M. L.; McCarthy, C.; Rizvi, H.; Yu, C.; Kehl, K. L.; Sweeney, S. M.; Rudolph, J. E.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Ignoring left truncation in overall survival within real-world genomic-phenomic data leads to inflated survival estimates
    Meeting Abstract

    Brown, S.; Lavery, J. A.; Lepisto, E. M.; McCarthy, C.; Rizvi, H.; Yu, C.; Kehl, K. L.; Sweeney, S. M.; Rudolph, J. E.; Schultz, N.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • A very high tumor mutational burden (TMB) is associated with improved efficacy of PD-(L)1 inhibition across different PD-L1 expression subgroups and a distinct immunophenotype in NSCLC
    Meeting Abstract

    Ricciuti, B.; Arbour, K. C.; Mahadevan, N. R.; Alessi, J. V.; Lindsay, J.; Umeton, R.; Sinha, R.; Hoojghan, A.; Vokes, N.; Recondo, G.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Tim-4(+) cavity-resident macrophages impair anti-tumor CD8(+) T cell immunity
    Journal Article

    Chow, A.; Schad, S.; Green, M. D.; Hellmann, M. D.; Allaj, V.; Ceglia, N.; Zago, G.; Shah, N. S.; Sharma, S. K.; Mattar, M.; more...
    Cancer Cell (2021)

    Fulltext@MSK | Save
  • Predicting immunotherapy outcomes under therapy in patients with advanced NSCLC using dNLR and its early dynamics
    Journal Article

    Mezquita, L.; Preeshagul, I.; Auclin, E.; Saravia, D.; Hendriks, L.; Rizvi, H.; Park, W.; Nadal, E.; Martin-Romano, P.; Ruffinelli, J. C.; more...
    European Journal of Cancer (2021)

    Fulltext@MSK | Save
  • Response to standard therapies and comprehensive genomic analysis for patients with lung adenocarcinoma with EGFR exon 20 insertions
    Journal Article

    Choudhury, N. J.; Schoenfeld, A. J.; Flynn, J.; Falcon, C. J.; Rizvi, H.; Rudin, C. M.; Kris, M. G.; Arcila, M. E.; Heller, G.; Yu, H. A.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Diminished efficacy of PD-(L)1 inhibition in STK11- and KEAP1-mutant lung adenocarcinoma is impacted by KRAS mutation status
    Meeting Abstract

    Ricciuti, B.; Arbour, K.; Lin, J.; Vajdi, A.; Tolstorukov, M.; Hong, L.; Zhang, J.; Vokes, N.; Li, Y.; Spurr, L.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Treatment outcomes and clinical characteristics of patients with KRAS-G12C-mutant non-small cell lung cancer
    Journal Article

    Arbour, K. C.; Rizvi, H.; Plodkowski, A. J.; Hellmann, M. D.; Knezevic, A.; Heller, G.; Yu, H. A.; Ladanyi, M.; Kris, M. G.; Arcila, M. E.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • A genomic-pathologic annotated risk model to predict recurrence in early-stage lung adenocarcinoma
    Journal Article

    Jones, G. D.; Brandt, W. S.; Shen, R.; Sanchez-Vega, F.; Tan, K. S.; Martin, A.; Zhou, J.; Berger, M.; Solit, D. B.; Schultz, N.; more...
    JAMA Surgery (2021)

    Fulltext@MSK | Save
  • Success and failure of additional immune modulators in steroid-refractory/resistant pneumonitis related to immune checkpoint blockade
    Journal Article

    Beattie, J.; Rizvi, H.; Fuentes, P.; Luo, J.; Schoenfeld, A.; Lin, I. H.; Postow, M.; Callahan, M.; Voss, M. H.; Shah, N. J.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save